Approximately one in 10 adult Australians have indicators of chronic kidney disease, a serious condition that can progress to end-stage kidney disease. There is little we can do to delay this progression, but we do know that kidney inflammation is a key contributor in deterioration of kidney function.
New therapeutic approaches we have developed include cell therapies and DNA vaccines to target kidney inflammation.
Our research aims to understand the mechanisms underlying kidney inflammation and develop novel therapeutic strategies to reverse or delay progression of chronic kidney disease to kidney failure.
Our laboratory research has the potential to be translated into new treatments for patients with kidney disease.